Daewon Pharm (003220) — Cash Flow Reinvestment Rate
Daewon Pharm (003220) has a Cash Flow Reinvestment Rate of 0.52x as of December 2025, reinvesting ₩15.94 Billion (capex ₩13.07 Billion plus investments ₩2.87 Billion) from operating cash flow of ₩30.61 Billion. Explore Daewon Pharm (003220) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Daewon Pharm Cash Flow Reinvestment Rate (2011–2025)
Historical reinvestment intensity for Daewon Pharm across 15 annual periods. Also explore 003220 current and non-current assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Daewon Pharm (2011–2025)
Year-by-year capital reinvestment analysis for Daewon Pharm. For live market cap and broader valuation context, see market value of Daewon Pharm.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.14x | ₩48.21 Billion | ₩42.31 Billion | ₩42.13 Billion | ▼ -48.1% |
| 2024 | 2.20x | ₩65.99 Billion | ₩30.04 Billion | ₩53.58 Billion | ▲ +27.9% |
| 2023 | 1.72x | ₩88.88 Billion | ₩51.73 Billion | ₩20.61 Billion | ▲ +39.5% |
| 2022 | 1.23x | ₩41.05 Billion | ₩33.33 Billion | ₩13.37 Billion | ▲ +35.6% |
| 2021 | 0.91x | ₩20.36 Billion | ₩22.41 Billion | ₩4.10 Billion | ▲ +99.2% |
| 2020 | 0.46x | ₩11.38 Billion | ₩24.95 Billion | ₩11.35 Billion | ▼ -68.8% |
| 2019 | 1.46x | ₩45.24 Billion | ₩30.97 Billion | ₩33.03 Billion | ▲ +39.8% |
| 2018 | 1.04x | ₩41.81 Billion | ₩40.03 Billion | ₩40.82 Billion | ▼ -72.8% |
| 2017 | 3.84x | ₩16.39 Billion | ₩4.27 Billion | ₩14.71 Billion | ▲ +96.1% |
| 2016 | 1.96x | ₩40.74 Billion | ₩20.79 Billion | ₩20.57 Billion | ▲ +142.1% |
| 2015 | 0.81x | ₩20.89 Billion | ₩25.82 Billion | ₩19.80 Billion | ▼ -21.5% |
| 2014 | 1.03x | ₩17.98 Billion | ₩17.45 Billion | ₩15.84 Billion | ▼ -24.7% |
| 2013 | 1.37x | ₩16.85 Billion | ₩12.32 Billion | ₩9.85 Billion | ▲ +472.4% |
| 2012 | 0.24x | ₩3.30 Billion | ₩13.83 Billion | ₩3.30 Billion | ▼ -58.0% |
| 2011 | 0.57x | ₩10.19 Billion | ₩17.93 Billion | ₩10.19 Billion | — |